Atossa Therapeutics, Inc. (ATOS)
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patients; AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.
$189.26M
Dr. Steven C. Quay FCAP, M.D., Ph.D.
6.00
Seattle, WA
Nov 08, 2012
-7.17
$-0.21
13.98
14.35
-143,944.44%
-7.38
0.07
2.38
10,619.48
14.35
-30.18%
-29.18%
Similar stocks (14)
Novavax, Inc.
NVAX
Ocugen, Inc.
OCGN
Vaxart, Inc.
VXRT
Inovio Pharmaceuticals, Inc.
INO
Elevation Oncology, Inc.
ELEV
Ocean Biomedical, Inc.
OCEA
GeoVax Labs, Inc.
GOVX
iBio, Inc.
IBIO
Jaguar Health, Inc.
JAGX
Palisade Bio, Inc.
PALI
Sonnet BioTherapeutics Holdings, Inc.
SONN
Enveric Biosciences, Inc.
ENVB
Tonix Pharmaceuticals Holding Corp.
TNXP
CohBar, Inc.
CWBR
ETF Exposure (21)
iShares Micro-Cap ETF
IWC
0.04637%
iShares Russell 2000 Value ETF
IWN
0.0109%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 ETF
IWM
0.00674%
ProShares Ultra Russell2000
UWM
0.002547926542488881%
iShares Russell 2000 Growth ETF
IWO
0.00247%
ProShares UltraPro Russell2000
URTY
0.0012561158552205087%
ProShares Hedge Replication ETF
HDG
0.0010644580168107391%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Growth Index Fund
VTWG
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (14)
Novavax, Inc.
NVAX
Ocugen, Inc.
OCGN
Vaxart, Inc.
VXRT
Inovio Pharmaceuticals, Inc.
INO
Elevation Oncology, Inc.
ELEV
Ocean Biomedical, Inc.
OCEA
GeoVax Labs, Inc.
GOVX
iBio, Inc.
IBIO
Jaguar Health, Inc.
JAGX
Palisade Bio, Inc.
PALI
Sonnet BioTherapeutics Holdings, Inc.
SONN
Enveric Biosciences, Inc.
ENVB
Tonix Pharmaceuticals Holding Corp.
TNXP
CohBar, Inc.
CWBR
ETF Exposure (21)
iShares Micro-Cap ETF
IWC
0.04637%
iShares Russell 2000 Value ETF
IWN
0.0109%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 ETF
IWM
0.00674%
ProShares Ultra Russell2000
UWM
0.002547926542488881%
iShares Russell 2000 Growth ETF
IWO
0.00247%
ProShares UltraPro Russell2000
URTY
0.0012561158552205087%
ProShares Hedge Replication ETF
HDG
0.0010644580168107391%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Growth Index Fund
VTWG
0%
Vanguard Extended Market Index Fund
VXF
0%